Protocol Ledger

NCT07057037 · Phase III · ACTIVE NOT RECRUITING

Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases

Interventional Phase III clinical trial protocol NCT07057037 sponsored by Inventera in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-09-23 Enrollment: 85 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07057037
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)85 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07057037
Protocol FieldVerified Registry Value
NCT IdentifierNCT07057037
Consolidated Lead SponsorInventera
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment85 participants (ESTIMATED)
Registered Start Date2025-09-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07057037
Hospital Research SiteLocationSite Profile
Seoul National University Bundang HospitalSeongnam-si, South KoreaOpen Hospital Dossier ->
Seoul National University HospitalSeoul, South KoreaOpen Hospital Dossier ->
Yonsei University Health System, Severance HospitalSeoul, South KoreaOpen Hospital Dossier ->
Konkuk University Medical CenterSeoul, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI